Background Tuberculosis (TB) treatment monitoring relies on sputum-based microbiological assays, which are slow and provide limited insight into the host response. Blood-based biomarkers could offer rapid and minimally invasive treatment monitoring. Methods We performed an integrative multi-omics analysis of paired who...
G. V. Anoushka Chinmayi, Darla Quijada, A. Queiroz et al.· bioRxiv· 0 citations
Background: Tuberculosis (TB) remains the leading infectious disease cause of mortality worldwide. A subset of individuals exposed to Mycobacterium tuberculosis (Mtb) remain TST/IGRA-negative despite sustained exposure, termed "TB resisters". The biological mechanisms underlying this resistance remain poorly understood...
Chang Liu, Jeffrey M. Collins, M. F. Gyorfy et al.· medRxiv· 0 citations
BACKGROUND
Millions of individuals at risk of tuberculosis are given tuberculosis preventive treatment (TPT) annually. However, questions remain regarding the duration of protection from TPT and potential variability across populations and settings with disparate tuberculosis risk. We aimed to assess the effect of TPT...
Lauren Linde, Jeffrey I. Campbell, C. Horsburgh et al.· The Lancet Respiratory Medic...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.